Bayer says profits up 54% in first quarter
German chemicals and pharmaceuticals giant Bayer, maker of Aspirin, said on Thursday it got off to an 'encouraging start' to 2012 with net profit soaring 53.5 per cent in the first three months.
"The
Regular aspirin users ‘twice as likely to suffer vision loss later in life’
A new study has suggested that people who take a daily dose of aspirin are twice as likely to suffer blindness in later life.
Researchers who tested more than 4,000 elderly people across Europe found
Aspirin reduces cancer
London, Dec. 7: A daily low dose of aspirin significantly reduces the number of deaths from a whole range of common cancers, according to a recent study by the Oxford University.
The 20 per cent drop